CN107884490B - Method for simultaneously detecting multiple progestogens in environmental water body - Google Patents
Method for simultaneously detecting multiple progestogens in environmental water body Download PDFInfo
- Publication number
- CN107884490B CN107884490B CN201711083232.8A CN201711083232A CN107884490B CN 107884490 B CN107884490 B CN 107884490B CN 201711083232 A CN201711083232 A CN 201711083232A CN 107884490 B CN107884490 B CN 107884490B
- Authority
- CN
- China
- Prior art keywords
- water
- progesterone
- phase extraction
- solid phase
- progestogens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 100
- 238000000034 method Methods 0.000 title claims abstract description 33
- 230000007613 environmental effect Effects 0.000 title claims abstract description 31
- 239000000583 progesterone congener Substances 0.000 title claims abstract description 22
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 title claims abstract description 13
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims abstract description 104
- 239000000186 progesterone Substances 0.000 claims abstract description 54
- 229960003387 progesterone Drugs 0.000 claims abstract description 52
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 48
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 claims abstract description 23
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 239000003463 adsorbent Substances 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 60
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- 239000012224 working solution Substances 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 238000001179 sorption measurement Methods 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 14
- -1 lipid compound Chemical class 0.000 claims description 13
- 239000010865 sewage Substances 0.000 claims description 13
- 239000012086 standard solution Substances 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 13
- 239000003480 eluent Substances 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 239000000835 fiber Substances 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 claims description 10
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 10
- 239000011258 core-shell material Substances 0.000 claims description 10
- 238000004807 desolvation Methods 0.000 claims description 10
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 10
- 238000010828 elution Methods 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 229940053934 norethindrone Drugs 0.000 claims description 10
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000011550 stock solution Substances 0.000 claims description 10
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 claims description 10
- 229940117972 triolein Drugs 0.000 claims description 10
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 10
- 239000012498 ultrapure water Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000004949 mass spectrometry Methods 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 7
- 238000005259 measurement Methods 0.000 claims description 6
- 239000002243 precursor Substances 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 claims description 5
- RJKFOVLPORLFTN-PQIPVKAESA-N (8s,9s,10r,13s,14s,17s)-2,2,4,6,6,17-hexadeuterio-10,13-dimethyl-17-(2,2,2-trideuterioacetyl)-7,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C([C@]1(C)[C@@]([2H])(C(=O)C([2H])([2H])[2H])CC[C@H]1[C@@H]1CC2([2H])[2H])C[C@@H]1[C@]1(C)C2=C([2H])C(=O)C([2H])([2H])C1 RJKFOVLPORLFTN-PQIPVKAESA-N 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 claims description 5
- 229960004845 drospirenone Drugs 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000132 electrospray ionisation Methods 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 229960004400 levonorgestrel Drugs 0.000 claims description 5
- 230000014759 maintenance of location Effects 0.000 claims description 5
- 229960004616 medroxyprogesterone Drugs 0.000 claims description 5
- FRQMUZJSZHZSGN-HBNHAYAOSA-N medroxyprogesterone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FRQMUZJSZHZSGN-HBNHAYAOSA-N 0.000 claims description 5
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 claims description 5
- 229960003248 mifepristone Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000010926 purge Methods 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000003260 vortexing Methods 0.000 claims description 5
- 239000007790 solid phase Substances 0.000 claims description 2
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 9
- 239000011159 matrix material Substances 0.000 abstract description 8
- 239000012491 analyte Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000005416 organic matter Substances 0.000 abstract description 2
- 150000003146 progesterones Chemical class 0.000 abstract description 2
- 239000002594 sorbent Substances 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 4
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000000944 Soxhlet extraction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000874 microwave-assisted extraction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001044 reversed-phase solid-phase extraction Methods 0.000 description 2
- 238000002470 solid-phase micro-extraction Methods 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 230000009547 development abnormality Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
- G01N2030/045—Standards internal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
本发明公开了一种同时检测环境水体中多种孕激素的方法,属于环境中有机物分析领域,包括水样预处理、新型固相萃取吸附剂Oasis PRiME HLB富集浓缩、UPLC‑MS/MS测定孕激素浓度、标准曲线的绘制及上机测定五个步骤,采用新型固相萃取吸附剂Oasis PRiME HLB作为环境水样的预处理技术,既提高了对待测物的选择性,也大大增加了富集倍数和降低了基质效应,并且以超高液相‑质谱连用仪为检测定量工具,同时测定了水环境中11种不同孕激素,与普通的检测方式相比,实现了对孕激素的高选择性和高灵敏度的有效结合,且具有分析速度快、使用范围广等优点。
The invention discloses a method for simultaneously detecting multiple progestogens in environmental water, belonging to the field of organic matter analysis in the environment, including water sample pretreatment, novel solid-phase extraction adsorbent Oasis PRiME HLB enrichment and concentration, UPLC-MS/MS determination The five steps of progesterone concentration, standard curve drawing and on-board determination, using the new solid phase extraction sorbent Oasis PRiME HLB as the pretreatment technology of environmental water samples, not only improves the selectivity of the analyte, but also greatly increases the richness. The multiplexing and matrix effects are reduced, and 11 different progesterones in the water environment are simultaneously measured by using the ultra-high liquid phase-mass spectrometer as the detection and quantitative tool. It is an effective combination of selectivity and high sensitivity, and has the advantages of fast analysis speed and wide application range.
Description
技术领域technical field
本发明属于环境水体中有机物分析技术领域,具体涉及一种同时检测环境水体中多种孕激素的方法。The invention belongs to the technical field of organic matter analysis in environmental water bodies, and particularly relates to a method for simultaneously detecting multiple progestogens in environmental water bodies.
背景技术Background technique
在过去半个世纪,孕激素对人类和野生动物赖以生存的自然环境造成了严重的危害,已经成为全球范围内共同亟待解决的环境污染问题,引起了人们的广泛关注。孕激素作为一种常见的内分泌干扰物可长期蓄积在环境与人体内,代谢缓慢,可通过扩散、对流转移至大气、土壤,水域沉积物等各种环境介质中。一旦进入机体,不仅可以扰乱机体正常的内分泌激素的合成与代谢,影响生长发育和性别分化,还能引起神经、内分泌、免疫等多系统发育异常和生殖障碍,甚至致畸和致癌等。因此,建立快速、高效、准确、灵敏的环境水体中孕激素分析检测方法非常重要。In the past half century, progesterone has caused serious harm to the natural environment on which humans and wild animals depend. As a common endocrine disruptor, progesterone can accumulate in the environment and human body for a long time, and its metabolism is slow, and it can be transferred to various environmental media such as atmosphere, soil, and water sediments through diffusion and convection. Once it enters the body, it can not only disrupt the body's normal synthesis and metabolism of endocrine hormones, affect growth and gender differentiation, but also cause neurological, endocrine, immune and other multi-system developmental abnormalities and reproductive disorders, and even cause teratogenicity and carcinogenesis. Therefore, it is very important to establish a fast, efficient, accurate and sensitive method for the analysis and detection of progesterone in environmental water.
由于环境样品形态多样、成分复杂而且孕激素含量较低的特点,难以直接对其进行分析检测。为了减少样品基底的干扰和提高分析检测灵敏度,在进行样品分析前必须进行合适的样品预处理才能进行各种仪器分析。环境样品中环境激素预处理技术的传统方法有超声波提取、索氏提取、微波萃取等。但超声波提取溶剂消耗量大、索氏提取时间长,且需要回流操作;微波萃取后需要过滤,难以与仪器联机。目前,随着科技的发展,很多新型的样品预处理技术应运而生,如SPE、SPME。SPME技术作为一种新型的样品前处理技术,随着其应用领域的不断扩大,但其萃取纤维本身的一些局限性导致新问题不断出现,回收率和重复性得不到保证。而SPE可以作为环境激素预处理的一种新型技术,其回收率较高和重现性较稳定,但由于环境样品形态多样、成分复杂而且待测物含量较低的特点,对SPE技术提出了更高的要求。Oasis PRiME HLB作为一种新型反相固相萃取吸附剂,能够简化和加速SPE流程,它可以在更短的时间内提供更洁净的样品,使液相色谱和液质联用系统的分析更为轻松。Oasis PRiME HLB柱还可以和多孔板可简化萃取流程并加快萃取速度,确保获得一致、可重现的液相和液质联用分析结果。相比于使用其它萃取技术制备样品,分析实验室现在能够更快速地处理样品,速度提升最高40%,而样品洁净度的提高可达70%,并且液质联用的基质效应更小。同时较其它样品前处理方法能够获得更洁净的萃取物。Oasis PRiME HLB是一款非常成功的新一代反相SPE产品,它能够通过更简单的方案、更短的处理时间获得更洁净的提取物,能有效的富集浓缩环境水体中的孕激素,能够作为一种处理环境水体中孕激素的预处理方法。Due to the diverse morphology, complex composition and low progesterone content of environmental samples, it is difficult to directly analyze and detect them. In order to reduce the interference of the sample substrate and improve the analytical detection sensitivity, appropriate sample pretreatment must be carried out before the sample analysis can be carried out for various instrumental analysis. The traditional methods of environmental hormone pretreatment technology in environmental samples include ultrasonic extraction, Soxhlet extraction, microwave extraction and so on. However, the ultrasonic extraction solvent consumption is large, the Soxhlet extraction time is long, and reflux operation is required; after microwave extraction, filtration is required, which is difficult to connect with the instrument. At present, with the development of science and technology, many new sample pretreatment technologies have emerged, such as SPE and SPME. As a new type of sample pretreatment technology, SPME technology continues to expand with the continuous expansion of its application field, but some limitations of its extraction fiber itself lead to the emergence of new problems, and the recovery rate and repeatability cannot be guaranteed. SPE can be used as a new technology for environmental hormone pretreatment, with high recovery rate and stable reproducibility. higher requirement. Oasis PRiME HLB is a novel reversed-phase solid-phase extraction sorbent that simplifies and accelerates SPE processes, providing cleaner samples in less time, making LC and LC/MS systems more efficient easy. Oasis PRiME HLB columns can also be combined with multiwell plates to simplify and speed up extraction, ensuring consistent and reproducible LC and LC/MS results. Analytical laboratories can now process samples faster than other extraction techniques, up to 40% faster, with up to 70% improved sample cleanliness and less matrix effects by LC/MS. At the same time, cleaner extracts can be obtained than other sample preparation methods. Oasis PRiME HLB is a very successful next-generation reversed-phase SPE product, which can obtain cleaner extracts through simpler protocols and shorter processing times, and can effectively enrich progesterone in concentrated environmental water. As a pretreatment method for the treatment of progesterone in environmental water.
发明内容SUMMARY OF THE INVENTION
针对以上技术问题,本发明提供一种同时检测环境水体中多种孕激素的方法,能有效的去除环境水体杂质,大大降低了基质效应。In view of the above technical problems, the present invention provides a method for simultaneously detecting multiple progestogens in environmental water, which can effectively remove impurities in environmental water and greatly reduce the matrix effect.
本发明的技术方案为:一种同时检测环境水体中多种孕激素的方法,将待测样品经过新型固相萃取吸附剂Oasis PRiME HLB预处理后,再用UPLC-MS/MS检测,包括以下步骤:The technical scheme of the present invention is as follows: a method for simultaneously detecting a variety of progesterone in environmental water, the sample to be tested is pretreated by a novel solid phase extraction adsorbent Oasis PRiME HLB, and then detected by UPLC-MS/MS, including the following step:
(1)水样预处理(1) Water sample pretreatment
将采集的水样采用三种不同孔径的滤膜进行三级过滤,精确量取过滤后的水样0.2-2L,并利用浓度为0.1mol/L盐酸和0.1mol/L氢氧化钠调节pH至7.0-7.2;The collected water samples are filtered with three different pore size membranes for tertiary filtration, accurately measure 0.2-2L of the filtered water samples, and adjust the pH to 0.1mol/L hydrochloric acid and 0.1mol/L sodium hydroxide. 7.0-7.2;
(2)新型固相萃取吸附剂Oasis PRiME HLB富集浓缩(2) New solid phase extraction adsorbent Oasis PRiME HLB enrichment and concentration
将步骤(1)处理过的水样直接过Oasis PRiME HLB固相萃取小柱进行富集,流速控制在7-9mL/min,待富集结束后使用超纯水分两次淋洗所述固相萃取小柱,然后将淋洗后的固相萃取小柱在真空干燥箱中干燥1-3h,干燥温度为25-35℃,利用乙酸乙酯对干燥后的固相萃取小柱进行三次洗脱,得到含目标化合物的洗脱液,将所述洗脱液移至氮气吹干仪中,用流速为1.5-2m/s的氮气吹扫30-60min,得到残渣备用;The water sample processed in step (1) was directly enriched through the Oasis PRiME HLB solid phase extraction cartridge, and the flow rate was controlled at 7-9 mL/min. After the enrichment was completed, the solid phase was washed twice with ultrapure water. Phase extraction cartridge, and then dry the rinsed solid phase extraction cartridge in a vacuum drying oven for 1-3 hours at a drying temperature of 25-35 °C, and wash the dried solid phase extraction cartridge three times with ethyl acetate. to obtain an eluent containing the target compound, move the eluent to a nitrogen blow dryer, and purge with nitrogen with a flow rate of 1.5-2 m/s for 30-60 min to obtain a residue for later use;
(3)UPLC-MS/MS测定孕激素浓度(3) Determination of progesterone concentration by UPLC-MS/MS
配制标准溶液:分别精确称取1mg所检测孕激素的标准品,并分别使用甲醇定容于100mL的容量瓶中,混合后得到10mg/L的混标储备溶液,于-20℃冰箱中储存;Preparation of standard solution: Accurately weigh 1 mg of the tested progesterone standard, respectively, and dilute to a 100-mL volumetric flask with methanol. After mixing, a 10 mg/L mixed standard stock solution is obtained, which is stored in a -20°C refrigerator;
配制工作溶液:精密量取甲醇溶液500μL溶解步骤(2)中的所述残渣,涡旋后,用玻璃滴管定容1mL并用0.22μm滤膜过滤,再用甲醇溶液进行稀释,得到不同浓度的工作溶液;Preparation of working solution: Precisely measure 500 μL of methanol solution to dissolve the residue in step (2), after vortexing, dilute to 1 mL with a glass dropper and filter with a 0.22 μm filter membrane, and then dilute with methanol solution to obtain different concentrations of working solution;
色谱条件:色谱柱ACQUITY UPLC BEH C18,2.1×100mm,1.7μm;流动相A为0.1%的甲酸,流动相B为甲醇,采用梯度洗脱程序;流速为0.3mL/min;柱温为40℃,进样量为10μL;其中所述梯度洗脱程序如下所示:Chromatographic conditions: column ACQUITY UPLC BEH C18, 2.1×100 mm, 1.7 μm; mobile phase A is 0.1% formic acid, mobile phase B is methanol, gradient elution procedure is used; flow rate is 0.3 mL/min; column temperature is 40 °C , the injection volume is 10 μL; the gradient elution procedure is as follows:
质谱条件:采用多反应检测模式,离子源为电喷雾离子化源(ESI源),源温度为120℃,锥孔电压:30V,提取离子电压为2.5kV,毛细管电压为3kV,脱溶剂气温度为450℃,脱溶剂气流速为900L/hr;扫描时间为0.1s;Mass spectrometry conditions: use multiple reaction detection mode, ion source is electrospray ionization source (ESI source), source temperature is 120 ° C, cone voltage: 30 V, extraction ion voltage is 2.5 kV, capillary voltage is 3 kV, desolvation gas temperature is 450℃, the flow rate of desolvation gas is 900L/hr; the scanning time is 0.1s;
(4)标准曲线的绘制(4) Drawing of standard curve
以步骤(3)中所述混标储备溶液浓度(mg/L)为横坐标,响应值为纵坐标绘制孕激素的标准曲线;Taking the mixed standard stock solution concentration (mg/L) described in the step (3) as the abscissa, the response value is the standard curve of the progesterone drawn on the ordinate;
(5)上机测定(5) On-board measurement
将步骤(3)中所述的工作溶液使用UPLC-MS/MS仪器检测,得到实际样品的典型色谱图,将所述实际样品典型色谱图与所述标准曲线进行比对进行定性检测;再使用UPLC-MS/MS仪器的调谐功能,确定各个物质的母离子、子离子、碰撞电压和毛细电压,使用上述参数对工作溶液中的孕激素进行定量检测。Detect the working solution described in step (3) using UPLC-MS/MS instrument to obtain a typical chromatogram of the actual sample, and compare the typical chromatogram of the actual sample with the standard curve for qualitative detection; then use The tuning function of the UPLC-MS/MS instrument determines the precursor ion, product ion, collision voltage and capillary voltage of each substance, and uses the above parameters to quantitatively detect progesterone in the working solution.
进一步地,所述孕激素分别为米非司酮、氯地孕酮、安宫黄体酮、屈螺酮、孕酮、甲炔诺酮、去氢孕酮、左炔诺孕酮、炔诺酮、孕酮-d9、炔诺酮-d6。Further, the progestogens are respectively mifepristone, clodesterone, medroxyprogesterone, drospirenone, progesterone, norethindrone, dehydroprogesterone, levonorgestrel, norethisterone , progesterone-d9, norethisterone-d6.
进一步地,所述环境水体为污水处理厂进水、出水和河水,两种水源人体接触率高,代表性更强。Further, the environmental water bodies are the influent water, the effluent water and the river water of the sewage treatment plant, and the two water sources have a high human contact rate and are more representative.
更进一步地,所述步骤(1)中当所述水样为污水处理厂进水水样时采集量为200-500mL,当水样为污水处理厂出水水样时采集量为300-500mL,当水样为河水时采集量为1-2L。Further, in the step (1), the collection amount is 200-500mL when the water sample is the sewage treatment plant influent water sample, and the collection amount is 300-500mL when the water sample is the sewage treatment plant effluent water sample, When the water sample is river water, the collection volume is 1-2L.
进一步地,步骤(2)中所述Oasis PRiME HLB固相萃取小柱内部含有复合吸附填料,所述复合吸附填料为质量比为2:1:1的聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂、三油酸甘油酯纤维球、核壳型葡萄糖聚合物-硅胶球,所述聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂通过一个“特殊的极性捕获基团”来增加对极性物质的保留提供很好的水浸润性;所述三油酸甘油酯纤维球具有较强的亲脂性,对孕激素这种类脂类化合物吸附力强且性能稳定;所述核壳型葡萄糖聚合物-硅胶球具有高度亲水性,富集分离效果良好。Further, the Oasis PRiME HLB solid phase extraction small column described in the step (2) contains composite adsorption fillers, and the composite adsorption fillers are poly-N-vinylpyrrolidone-divinylbenzene with a mass ratio of 2:1:1. Porous resins, triolein fiber spheres, core-shell glucose polymer-silica spheres, the poly-N-vinylpyrrolidone-divinylbenzene macroporous resin increases the The retention of polar substances provides good water wettability; the triolein fiber spheres have strong lipophilicity, and have strong adsorption force and stable performance for progesterone, a lipid compound; the core-shell glucose The polymer-silica spheres are highly hydrophilic and have good enrichment and separation effects.
进一步地,所述Oasis PRiME HLB固相萃取小柱不用进行活化和平衡,大大节省了操作时间和溶剂。Further, the Oasis PRiME HLB solid phase extraction cartridge does not need to be activated and equilibrated, which greatly saves operation time and solvent.
进一步地,步骤(1)中所述滤膜的孔径分别为10μm、1μm和0.45μm,梯度过滤,可最大化减小杂质影响分析结果。Further, the pore sizes of the filter membranes in step (1) are respectively 10 μm, 1 μm and 0.45 μm, and gradient filtration can minimize the influence of impurities on the analysis results.
进一步地,步骤(2)中所述超纯水与乙酸乙酯的用量均为所述固相萃取小柱体积的1-2倍。Further, the consumption of the ultrapure water and ethyl acetate in step (2) is 1-2 times the volume of the solid phase extraction cartridge.
与现有技术相比,本发明的有益效果为:Compared with the prior art, the beneficial effects of the present invention are:
(1)本发明采用新型固相萃取吸附剂Oasis PRiME HLB作为环境水样的预处理技术,能有效的去除环境水体杂质,大大降低了基质效应。并结合UPLC-MS/MS作为检测器,能够快速精准的检测环境水体孕激素含量,检测结果准确、可靠。(1) The present invention adopts the novel solid phase extraction adsorbent Oasis PRiME HLB as the pretreatment technology of environmental water samples, which can effectively remove impurities in environmental water and greatly reduce the matrix effect. Combined with UPLC-MS/MS as a detector, it can quickly and accurately detect the content of progesterone in environmental water, and the detection results are accurate and reliable.
(2)本发明采用新型固相萃取吸附剂Oasis PRiME HLB既提高了对待测物的选择性,也大大增加了富集倍数和降低了基质效应,为前处理技术的开发应用提供了新思路,也为对环境中痕量药物残留的提取、浓缩与分离增加了新方法。(2) The present invention adopts the novel solid-phase extraction adsorbent Oasis PRiME HLB, which not only improves the selectivity of the analyte, but also greatly increases the enrichment multiple and reduces the matrix effect, which provides a new idea for the development and application of pretreatment technology, It also adds new methods for the extraction, concentration and separation of trace drug residues in the environment.
(3)本发明以超高液相-质谱连用仪为检测定量工具,同时测定了水环境中11种不同孕激素,与普通的检测方式相比,实现了对孕激素的高选择性和高灵敏度的有效结合,且具有分析速度快、使用范围广等优点。(3) The present invention uses an ultra-high liquid phase-mass spectrometer as a detection and quantitative tool, and simultaneously measures 11 different progesterones in the water environment. Compared with ordinary detection methods, high selectivity and high progesterone are realized It is an effective combination of sensitivity, and has the advantages of fast analysis speed and wide application range.
附图说明Description of drawings
图1为实施例2的固相萃取小柱种类对9种孕激素回收率的影响;Fig. 1 is the influence of the solid phase extraction cartridge type of embodiment 2 on 9 kinds of progesterone recovery rates;
图2为实施例2的不同pH对9种孕激素回收率的影响;Fig. 2 is the influence of different pH of embodiment 2 on the recovery rate of 9 kinds of progestogens;
图3为实施例2的不同淋洗液对9种孕激素的影响;Fig. 3 is the influence of different eluents of embodiment 2 on 9 kinds of progesterone;
图4为实施例2的不同洗脱液对9种孕激素回收率的影响;Fig. 4 is the influence of different eluents of embodiment 2 on the recovery rate of 9 kinds of progesterone;
图5.1-5.3为实施例2的11种孕激素提取离子流图。Figures 5.1-5.3 are ion chromatograms extracted from 11 kinds of progestogens in Example 2.
具体实施方式Detailed ways
实施例1Example 1
一种同时检测环境水体中多种孕激素的方法,其中,所述孕激素分别为米非司酮、氯地孕酮、安宫黄体酮、屈螺酮、孕酮、甲炔诺酮、去氢孕酮、左炔诺孕酮、炔诺酮、孕酮-d9、炔诺酮-d6。将待测样品经过新型固相萃取吸附剂Oasis PRiME HLB预处理后,再用UPLC-MS/MS检测,包括以下步骤:A method for simultaneously detecting multiple progestins in an environmental water body, wherein the progestins are respectively mifepristone, clodesterone, medroxyprogesterone, drospirenone, progesterone, norethindrone, and Hydroprogesterone, levonorgestrel, norethisterone, progesterone-d9, norethisterone-d6. The samples to be tested were pretreated with a new solid-phase extraction adsorbent, Oasis PRiME HLB, and then detected by UPLC-MS/MS, including the following steps:
(1)水样预处理(1) Water sample pretreatment
选取污水处理厂进水、出水和河水为水样,两种水源人体接触率高,代表性更强。将采集的水样采用10μm、1μm和0.45μm三种不同孔径的滤膜进行三级过滤,精确量取过滤后的水样,其中,污水处理厂进水水样为200mL,污水处理厂出水水样为300mL,河水采集量为1L,并利用浓度为0.1mol/L盐酸和0.1mol/L氢氧化钠调节pH至7.0;The influent water, effluent water and river water of the sewage treatment plant were selected as water samples. The two water sources had high human contact rates and were more representative. The collected water samples were filtered with three different pore sizes of 10 μm, 1 μm and 0.45 μm for three-stage filtration, and the filtered water samples were accurately measured. The sample is 300mL, the river water collection volume is 1L, and the pH is adjusted to 7.0 with the concentration of 0.1mol/L hydrochloric acid and 0.1mol/L sodium hydroxide;
(2)新型固相萃取吸附剂Oasis PRiME HLB富集浓缩(2) New solid phase extraction adsorbent Oasis PRiME HLB enrichment and concentration
Oasis PRiME HLB固相萃取小柱不用进行活化和平衡,大大节省了操作时间和溶剂,将步骤(1)处理过的水样直接过Oasis PRiME HLB固相萃取小柱进行富集,流速控制在7mL/min,待富集结束后使用超纯水分两次淋洗所述固相萃取小柱,然后将淋洗后的固相萃取小柱在真空干燥箱中干燥1h,干燥温度为25℃,利用乙酸乙酯对干燥后的固相萃取小柱进行三次洗脱,其中,所述超纯水与乙酸乙酯的用量均为所述固相萃取小柱体积的1倍,得到含目标化合物的洗脱液,将所述洗脱液移至氮气吹干仪中,用流速为1.5m/s的氮气吹扫30min,得到残渣备用;其中,所述Oasis PRiME HLB固相萃取小柱内部含有复合吸附填料,所述复合吸附填料为质量比为2:1:1的聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂、三油酸甘油酯纤维球、核壳型葡萄糖聚合物-硅胶球,所述聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂通过一个“特殊的极性捕获基团”来增加对极性物质的保留提供很好的水浸润性;所述三油酸甘油酯纤维球具有较强的亲脂性,对孕激素这种类脂类化合物吸附力强且性能稳定;所述核壳型葡萄糖聚合物-硅胶球具有高度亲水性,富集分离效果良好。The Oasis PRiME HLB solid phase extraction cartridge does not need to be activated and equilibrated, which greatly saves operation time and solvent. The water sample treated in step (1) is directly enriched through the Oasis PRiME HLB solid phase extraction cartridge, and the flow rate is controlled at 7mL /min, after the enrichment is completed, the solid phase extraction cartridge is rinsed twice with ultrapure water, and then the rinsed solid phase extraction cartridge is dried in a vacuum drying oven for 1 hour at a drying temperature of 25°C. The dried solid-phase extraction cartridge was eluted three times with ethyl acetate, wherein the amounts of the ultrapure water and ethyl acetate were 1 times the volume of the solid-phase extraction cartridge to obtain the target compound containing the target compound. Eluent, move the eluent to a nitrogen blower, and purge it with nitrogen with a flow rate of 1.5 m/s for 30 min to obtain a residue for later use; wherein, the Oasis PRiME HLB solid phase extraction cartridge contains composite adsorption filler, the composite adsorption filler is poly-N-vinylpyrrolidone-divinylbenzene macroporous resin, triolein fiber ball, core-shell glucose polymer-silica ball with a mass ratio of 2:1:1, The poly-N-vinylpyrrolidone-divinylbenzene macroporous resin increases the retention of polar substances through a "special polar capture group" to provide good water wettability; the triolein fiber The sphere has strong lipophilicity, strong adsorption force for progesterone, a lipid compound, and stable performance; the core-shell type glucose polymer-silica sphere has high hydrophilicity and good enrichment and separation effect.
(3)UPLC-MS/MS测定孕激素浓度(3) Determination of progesterone concentration by UPLC-MS/MS
配制标准溶液:分别精确称取1mg所检测孕激素的标准品,并分别使用甲醇定容于100mL的容量瓶中,混合后得到10mg/L的混标储备溶液,于-20℃冰箱中储存;Preparation of standard solution: Accurately weigh 1 mg of the tested progesterone standard, respectively, and dilute to a 100-mL volumetric flask with methanol. After mixing, a 10 mg/L mixed standard stock solution is obtained, which is stored in a -20°C refrigerator;
配制工作溶液:精密量取甲醇溶液500μL溶解步骤(2)中的所述残渣,涡旋后,用玻璃滴管定容1mL并用0.22μm滤膜过滤,再用甲醇溶液进行稀释,得到不同浓度的工作溶液;Preparation of working solution: Precisely measure 500 μL of methanol solution to dissolve the residue in step (2), after vortexing, dilute to 1 mL with a glass dropper and filter with a 0.22 μm filter membrane, and then dilute with methanol solution to obtain different concentrations of working solution;
色谱条件:色谱柱ACQUITY UPLC BEH C18,2.1×100mm,1.7μm;流动相A为0.1%的甲酸,流动相B为甲醇,采用梯度洗脱程序;流速为0.3mL/min;柱温为40℃,进样量为10μL;其中所述梯度洗脱程序如下所示:Chromatographic conditions: column ACQUITY UPLC BEH C18, 2.1×100 mm, 1.7 μm; mobile phase A is 0.1% formic acid, mobile phase B is methanol, gradient elution procedure is used; flow rate is 0.3 mL/min; column temperature is 40 °C , the injection volume is 10 μL; the gradient elution procedure is as follows:
质谱条件:采用多反应检测模式,离子源为电喷雾离子化源(ESI源),源温度为120℃,锥孔电压:30V,提取离子电压为2.5kV,毛细管电压为3kV,脱溶剂气温度为450℃,脱溶剂气流速为900L/hr;扫描时间为0.1s;Mass spectrometry conditions: use multiple reaction detection mode, ion source is electrospray ionization source (ESI source), source temperature is 120 ° C, cone voltage: 30 V, extraction ion voltage is 2.5 kV, capillary voltage is 3 kV, desolvation gas temperature is 450℃, the flow rate of desolvation gas is 900L/hr; the scanning time is 0.1s;
(4)标准曲线的绘制(4) Drawing of standard curve
以步骤(3)中所述混标储备溶液浓度(mg/L)为横坐标,响应值为纵坐标绘制孕激素的标准曲线;Taking the mixed standard stock solution concentration (mg/L) described in the step (3) as the abscissa, the response value is the standard curve of the progesterone drawn on the ordinate;
(5)上机测定(5) On-board measurement
将步骤(3)中所述的工作溶液使用UPLC-MS/MS仪器检测,得到实际样品的典型色谱图,将所述实际样品典型色谱图与所述标准曲线进行比对进行定性检测;再使用UPLC-MS/MS仪器的调谐功能,确定各个物质的母离子、子离子、碰撞电压和毛细电压,使用上述参数对工作溶液中的孕激素进行定量检测。Detect the working solution described in step (3) using UPLC-MS/MS instrument to obtain a typical chromatogram of the actual sample, and compare the typical chromatogram of the actual sample with the standard curve for qualitative detection; then use The tuning function of the UPLC-MS/MS instrument determines the precursor ion, product ion, collision voltage and capillary voltage of each substance, and uses the above parameters to quantitatively detect progesterone in the working solution.
实施例2Example 2
一种同时检测环境水体中多种孕激素的方法,其中,所述孕激素分别为米非司酮、氯地孕酮、安宫黄体酮、屈螺酮、孕酮、甲炔诺酮、去氢孕酮、左炔诺孕酮、炔诺酮、孕酮-d9、炔诺酮-d6。将待测样品经过新型固相萃取吸附剂Oasis PRiME HLB预处理后,再用UPLC-MS/MS检测,包括以下步骤:A method for simultaneously detecting multiple progestins in an environmental water body, wherein the progestins are respectively mifepristone, clodesterone, medroxyprogesterone, drospirenone, progesterone, norethindrone, and Hydroprogesterone, levonorgestrel, norethisterone, progesterone-d9, norethisterone-d6. The samples to be tested were pretreated with a new solid-phase extraction adsorbent, Oasis PRiME HLB, and then detected by UPLC-MS/MS, including the following steps:
(1)水样预处理(1) Water sample pretreatment
选取污水处理厂进水、出水和河水为水样,两种水源人体接触率高,代表性更强。将采集的水样采用10μm、1μm和0.45μm三种不同孔径的滤膜进行三级过滤,精确量取过滤后的水样,其中,污水处理厂进水水样为350mL,污水处理厂出水水样为400mL,河水采集量为1.5L,并利用浓度为0.1mol/L盐酸和0.1mol/L氢氧化钠调节pH至7.1;The influent water, effluent water and river water of the sewage treatment plant were selected as water samples. The two water sources had high human contact rates and were more representative. The collected water samples were filtered with three different pore sizes of 10 μm, 1 μm and 0.45 μm for three-stage filtration, and the filtered water samples were accurately measured. The sample is 400mL, the river water collection volume is 1.5L, and the pH is adjusted to 7.1 with the concentration of 0.1mol/L hydrochloric acid and 0.1mol/L sodium hydroxide;
(2)新型固相萃取吸附剂Oasis PRiME HLB富集浓缩(2) New solid phase extraction adsorbent Oasis PRiME HLB enrichment and concentration
Oasis PRiME HLB固相萃取小柱不用进行活化和平衡,大大节省了操作时间和溶剂,将步骤(1)处理过的水样直接过Oasis PRiME HLB固相萃取小柱进行富集,流速控制在8mL/min,待富集结束后使用超纯水分两次淋洗所述固相萃取小柱,然后将淋洗后的固相萃取小柱在真空干燥箱中干燥2h,干燥温度为30℃,利用乙酸乙酯对干燥后的固相萃取小柱进行三次洗脱,其中,所述超纯水与乙酸乙酯的用量均为所述固相萃取小柱体积的1.5倍,得到含目标化合物的洗脱液,将所述洗脱液移至氮气吹干仪中,用流速为1.8m/s的氮气吹扫45min,得到残渣备用;其中,所述Oasis PRiME HLB固相萃取小柱内部含有复合吸附填料,所述复合吸附填料为质量比为2:1:1的聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂、三油酸甘油酯纤维球、核壳型葡萄糖聚合物-硅胶球,所述聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂通过一个“特殊的极性捕获基团”来增加对极性物质的保留提供很好的水浸润性;所述三油酸甘油酯纤维球具有较强的亲脂性,对孕激素这种类脂类化合物吸附力强且性能稳定;所述核壳型葡萄糖聚合物-硅胶球具有高度亲水性,富集分离效果良好。The Oasis PRiME HLB solid phase extraction cartridge does not need to be activated and equilibrated, which greatly saves operation time and solvent. The water sample treated in step (1) is directly enriched through the Oasis PRiME HLB solid phase extraction cartridge, and the flow rate is controlled at 8mL /min, after the enrichment is over, use ultrapure water to rinse the solid phase extraction cartridge twice, and then dry the rinsed solid phase extraction cartridge in a vacuum drying oven for 2 hours at a drying temperature of 30°C. The dried solid-phase extraction cartridge was eluted three times with ethyl acetate, wherein the amounts of the ultrapure water and ethyl acetate were both 1.5 times the volume of the solid-phase extraction cartridge to obtain the target compound containing the target compound. Eluent, move the eluent to a nitrogen blower, and purge with nitrogen with a flow rate of 1.8 m/s for 45 min to obtain a residue for later use; wherein, the Oasis PRiME HLB solid phase extraction cartridge contains composite adsorption filler, the composite adsorption filler is poly-N-vinylpyrrolidone-divinylbenzene macroporous resin, triolein fiber ball, core-shell glucose polymer-silica ball with a mass ratio of 2:1:1, The poly-N-vinylpyrrolidone-divinylbenzene macroporous resin increases the retention of polar substances through a "special polar capture group" to provide good water wettability; the triolein fiber The sphere has strong lipophilicity, strong adsorption force for progesterone, a lipid compound, and stable performance; the core-shell type glucose polymer-silica sphere has high hydrophilicity and good enrichment and separation effect.
(3)UPLC-MS/MS测定孕激素浓度(3) Determination of progesterone concentration by UPLC-MS/MS
配制标准溶液:分别精确称取1mg所检测孕激素的标准品,并分别使用甲醇定容于100mL的容量瓶中,混合后得到10mg/L的混标储备溶液,于-20℃冰箱中储存;Preparation of standard solution: Accurately weigh 1 mg of the tested progesterone standard, respectively, and dilute to a 100-mL volumetric flask with methanol. After mixing, a 10 mg/L mixed standard stock solution is obtained, which is stored in a -20°C refrigerator;
配制工作溶液:精密量取甲醇溶液500μL溶解步骤(2)中的所述残渣,涡旋后,用玻璃滴管定容1mL并用0.22μm滤膜过滤,再用甲醇溶液进行稀释,得到不同浓度的工作溶液;Preparation of working solution: Precisely measure 500 μL of methanol solution to dissolve the residue in step (2), after vortexing, dilute to 1 mL with a glass dropper and filter with a 0.22 μm filter membrane, and then dilute with methanol solution to obtain different concentrations of working solution;
色谱条件:色谱柱ACQUITY UPLC BEH C18,2.1×100mm,1.7μm;流动相A为0.1%的甲酸,流动相B为甲醇,采用梯度洗脱程序;流速为0.3mL/min;柱温为40℃,进样量为10μL;其中所述梯度洗脱程序如下所示:Chromatographic conditions: column ACQUITY UPLC BEH C18, 2.1×100 mm, 1.7 μm; mobile phase A is 0.1% formic acid, mobile phase B is methanol, gradient elution procedure is used; flow rate is 0.3 mL/min; column temperature is 40 °C , the injection volume is 10 μL; the gradient elution procedure is as follows:
质谱条件:采用多反应检测模式,离子源为电喷雾离子化源(ESI源),源温度为120℃,锥孔电压:30V,提取离子电压为2.5kV,毛细管电压为3kV,脱溶剂气温度为450℃,脱溶剂气流速为900L/hr;扫描时间为0.1s;Mass spectrometry conditions: use multiple reaction detection mode, ion source is electrospray ionization source (ESI source), source temperature is 120 ° C, cone voltage: 30 V, extraction ion voltage is 2.5 kV, capillary voltage is 3 kV, desolvation gas temperature is 450℃, the flow rate of desolvation gas is 900L/hr; the scanning time is 0.1s;
(4)标准曲线的绘制(4) Drawing of standard curve
以步骤(3)中所述混标储备溶液浓度(mg/L)为横坐标,响应值为纵坐标绘制孕激素的标准曲线;Taking the mixed standard stock solution concentration (mg/L) described in the step (3) as the abscissa, the response value is the standard curve of the progesterone drawn on the ordinate;
(5)上机测定(5) On-board measurement
将步骤(3)中所述的工作溶液使用UPLC-MS/MS仪器检测,得到实际样品的典型色谱图,将所述实际样品典型色谱图与所述标准曲线进行比对进行定性检测;再使用UPLC-MS/MS仪器的调谐功能,确定各个物质的母离子、子离子、碰撞电压和毛细电压,使用上述参数对工作溶液中的孕激素进行定量检测。Detect the working solution described in step (3) using UPLC-MS/MS instrument to obtain a typical chromatogram of the actual sample, and compare the typical chromatogram of the actual sample with the standard curve for qualitative detection; then use The tuning function of the UPLC-MS/MS instrument determines the precursor ion, product ion, collision voltage and capillary voltage of each substance, and uses the above parameters to quantitatively detect progesterone in the working solution.
实施例3Example 3
一种同时检测环境水体中多种孕激素的方法,其中,所述孕激素分别为米非司酮、氯地孕酮、安宫黄体酮、屈螺酮、孕酮、甲炔诺酮、去氢孕酮、左炔诺孕酮、炔诺酮、孕酮-d9、炔诺酮-d6。将待测样品经过新型固相萃取吸附剂Oasis PRiME HLB预处理后,再用UPLC-MS/MS检测,包括以下步骤:A method for simultaneously detecting multiple progestins in an environmental water body, wherein the progestins are respectively mifepristone, clodesterone, medroxyprogesterone, drospirenone, progesterone, norethindrone, and Hydroprogesterone, levonorgestrel, norethisterone, progesterone-d9, norethisterone-d6. The samples to be tested were pretreated with a new solid-phase extraction adsorbent, Oasis PRiME HLB, and then detected by UPLC-MS/MS, including the following steps:
(1)水样预处理(1) Water sample pretreatment
选取污水处理厂进水、出水和河水为水样,两种水源人体接触率高,代表性更强。将采集的水样采用10μm、1μm和0.45μm三种不同孔径的滤膜进行三级过滤,精确量取过滤后的水样,其中,污水处理厂进水水样为500mL,污水处理厂出水水样为500mL,河水采集量为2L,并利用浓度为0.1mol/L盐酸和0.1mol/L氢氧化钠调节pH至7.2;The influent water, effluent water and river water of the sewage treatment plant were selected as water samples. The two water sources had high human contact rates and were more representative. The collected water samples were filtered with three different pore sizes of 10 μm, 1 μm and 0.45 μm for three-stage filtration, and the filtered water samples were accurately measured. The sample is 500mL, the river water collection volume is 2L, and the pH is adjusted to 7.2 with the concentration of 0.1mol/L hydrochloric acid and 0.1mol/L sodium hydroxide;
(2)新型固相萃取吸附剂Oasis PRiME HLB富集浓缩(2) New solid phase extraction adsorbent Oasis PRiME HLB enrichment and concentration
Oasis PRiME HLB固相萃取小柱不用进行活化和平衡,大大节省了操作时间和溶剂,将步骤(1)处理过的水样直接过Oasis PRiME HLB固相萃取小柱进行富集,流速控制在9mL/min,待富集结束后使用超纯水分两次淋洗所述固相萃取小柱,然后将淋洗后的固相萃取小柱在真空干燥箱中干燥3h,干燥温度为35℃,利用乙酸乙酯对干燥后的固相萃取小柱进行三次洗脱,其中,所述超纯水与乙酸乙酯的用量均为所述固相萃取小柱体积的2倍,得到含目标化合物的洗脱液,将所述洗脱液移至氮气吹干仪中,用流速为2m/s的氮气吹扫60min,得到残渣备用;其中,所述Oasis PRiME HLB固相萃取小柱内部含有复合吸附填料,所述复合吸附填料为质量比为2:1:1的聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂、三油酸甘油酯纤维球、核壳型葡萄糖聚合物-硅胶球,所述聚N-乙烯基吡咯烷酮-二乙烯苯大孔树脂通过一个“特殊的极性捕获基团”来增加对极性物质的保留提供很好的水浸润性;所述三油酸甘油酯纤维球具有较强的亲脂性,对孕激素这种类脂类化合物吸附力强且性能稳定;所述核壳型葡萄糖聚合物-硅胶球具有高度亲水性,富集分离效果良好。The Oasis PRiME HLB solid phase extraction cartridge does not need to be activated and equilibrated, which greatly saves operation time and solvent. The water sample treated in step (1) is directly enriched through the Oasis PRiME HLB solid phase extraction cartridge, and the flow rate is controlled at 9mL /min, after the enrichment is over, use ultrapure water to rinse the solid phase extraction cartridge twice, and then dry the rinsed solid phase extraction cartridge in a vacuum drying oven for 3 hours at a drying temperature of 35°C, The dried solid-phase extraction cartridge was eluted three times with ethyl acetate, wherein the amounts of the ultrapure water and ethyl acetate were both twice the volume of the solid-phase extraction cartridge to obtain the target compound-containing Eluent, move the eluent to a nitrogen blower, and purge with nitrogen with a flow rate of 2 m/s for 60 min to obtain a residue for later use; wherein, the Oasis PRiME HLB solid phase extraction cartridge contains composite adsorption Filler, the composite adsorption filler is poly-N-vinylpyrrolidone-divinylbenzene macroporous resin with mass ratio of 2:1:1, triolein fiber ball, core-shell glucose polymer-silica ball, so The poly-N-vinylpyrrolidone-divinylbenzene macroporous resin provides good water wettability through a "special polar capture group" to increase the retention of polar substances; the triolein fiber balls It has strong lipophilicity, strong adsorption force for progesterone, a lipid compound, and stable performance; the core-shell glucose polymer-silica ball has high hydrophilicity and good enrichment and separation effect.
(3)UPLC-MS/MS测定孕激素浓度(3) Determination of progesterone concentration by UPLC-MS/MS
配制标准溶液:分别精确称取1mg所检测孕激素的标准品,并分别使用甲醇定容于100mL的容量瓶中,混合后得到10mg/L的混标储备溶液,于-20℃冰箱中储存;Preparation of standard solution: Accurately weigh 1 mg of the tested progesterone standard, respectively, and dilute to a 100-mL volumetric flask with methanol. After mixing, a 10 mg/L mixed standard stock solution is obtained, which is stored in a -20°C refrigerator;
配制工作溶液:精密量取甲醇溶液500μL溶解步骤(2)中的所述残渣,涡旋后,用玻璃滴管定容1mL并用0.22μm滤膜过滤,再用甲醇溶液进行稀释,得到不同浓度的工作溶液;Preparation of working solution: Precisely measure 500 μL of methanol solution to dissolve the residue in step (2), after vortexing, dilute to 1 mL with a glass dropper and filter with a 0.22 μm filter membrane, and then dilute with methanol solution to obtain different concentrations of working solution;
色谱条件:色谱柱ACQUITY UPLC BEH C18,2.1×100mm,1.7μm;流动相A为0.1%的甲酸,流动相B为甲醇,采用梯度洗脱程序;流速为0.3mL/min;柱温为40℃,进样量为10μL;其中所述梯度洗脱程序如下所示:Chromatographic conditions: column ACQUITY UPLC BEH C18, 2.1×100 mm, 1.7 μm; mobile phase A is 0.1% formic acid, mobile phase B is methanol, gradient elution procedure is used; flow rate is 0.3 mL/min; column temperature is 40 °C , the injection volume is 10 μL; the gradient elution procedure is as follows:
质谱条件:采用多反应检测模式,离子源为电喷雾离子化源(ESI源),源温度为120℃,锥孔电压:30V,提取离子电压为2.5kV,毛细管电压为3kV,脱溶剂气温度为450℃,脱溶剂气流速为900L/hr;扫描时间为0.1s;Mass spectrometry conditions: use multiple reaction detection mode, ion source is electrospray ionization source (ESI source), source temperature is 120 ° C, cone voltage: 30 V, extraction ion voltage is 2.5 kV, capillary voltage is 3 kV, desolvation gas temperature is 450℃, the flow rate of desolvation gas is 900L/hr; the scanning time is 0.1s;
(4)标准曲线的绘制(4) Drawing of standard curve
以步骤(3)中所述混标储备溶液浓度(mg/L)为横坐标,响应值为纵坐标绘制孕激素的标准曲线;Taking the mixed standard stock solution concentration (mg/L) described in the step (3) as the abscissa, the response value is the standard curve of the progesterone drawn on the ordinate;
(5)上机测定(5) On-board measurement
将步骤(3)中所述的工作溶液使用UPLC-MS/MS仪器检测,得到实际样品的典型色谱图,将所述实际样品典型色谱图与所述标准曲线进行比对进行定性检测;再使用UPLC-MS/MS仪器的调谐功能,确定各个物质的母离子、子离子、碰撞电压和毛细电压,使用上述参数对工作溶液中的孕激素进行定量检测。Detect the working solution described in step (3) using UPLC-MS/MS instrument to obtain a typical chromatogram of the actual sample, and compare the typical chromatogram of the actual sample with the standard curve for qualitative detection; then use The tuning function of the UPLC-MS/MS instrument determines the precursor ion, product ion, collision voltage and capillary voltage of each substance, and uses the above parameters to quantitatively detect progesterone in the working solution.
结果分析Result analysis
以下是实施例3的上机测定结果分析:The following is the analysis of the measurement results on the machine of Example 3:
(一)定性检测(1) Qualitative detection
其中,以信噪比的3倍为方法的检测限,则检测限为0.1-0.8ng/L,灵敏度高;且线性相关系数均在0.99以上,线性关系良好。各工作溶液的标准曲线范围、相关系数、检测限等结果如表1所示:Among them, the detection limit of the method is 3 times of the signal-to-noise ratio, the detection limit is 0.1-0.8ng/L, and the sensitivity is high; and the linear correlation coefficients are all above 0.99, and the linear relationship is good. The results of the standard curve range, correlation coefficient and detection limit of each working solution are shown in Table 1:
表1方法学检测结果Table 1 Methodological test results
(二)定量检测(2) Quantitative detection
再使用UPLC-MS/MS仪器的调谐功能,确定各个物质的母离子、子离子、碰撞电压和毛细电压,使用上述参数对工作溶液中的孕激素进行定量检测。其中,11种孕激素定量分析质谱参数如表2所示:Then use the tuning function of the UPLC-MS/MS instrument to determine the precursor ion, product ion, collision voltage and capillary voltage of each substance, and use the above parameters to quantitatively detect progesterone in the working solution. Among them, 11 kinds of progesterone quantitative analysis mass spectrometry parameters are shown in Table 2:
表2 11种孕激素的质谱条件Table 2 Mass spectrometry conditions for 11 progestins
(三)基质效应计算(3) Calculation of matrix effect
A:将内标和标准溶液加入按上述步骤(1)处理的水样中,按照步骤(2)对上述孕激素进行提取并按照步骤(3)进行检测,结果定义为Cm;A: The internal standard and standard solution are added to the water sample processed by the above-mentioned steps (1), and the above-mentioned progesterone is extracted according to the step (2) and detected according to the step (3), and the result is defined as C m ;
B:相同的水样,不加内标和标准溶液,按照步骤(2)对上述孕激素进行提取,从提取液中取100μL,氮气吹干,然后加入100μL孕激素混标溶液(50μg/L),得到的结果定义为Cm+100;B: The same water sample, without adding internal standard and standard solution, extract the above progestogen according to step (2), take 100 μL from the extract, dry it with nitrogen, and then add 100 μL of mixed standard solution of progesterone (50 μg/L ), the obtained result is defined as C m+100 ;
C:孕激素的混标溶液(50μg/L)的标准溶液按照步骤(3)分析,结果定义为C100;则基质效应(ME%)的计算结果为ME%=[(Cm+100-Cm)/C100]×100%,结果如表3所示:C: The standard solution of the mixed standard solution of progesterone (50 μg/L) is analyzed according to step (3), and the result is defined as C 100 ; then the calculation result of the matrix effect (ME%) is ME%=[(C m+10 0 -C m )/C 100 ]×100%, the results are shown in Table 3:
表3孕激素基质效应(ME%)Table 3 Progestogen matrix effect (ME%)
(四)加标回收率计算(4) Calculation of standard addition recovery rate
D:取污水处理厂进水和出水以及河水水样,加入一定浓度的各待测物的标准溶液按上述步骤(1)处理的水样中,按上述步骤(2)富集浓缩后,按上述步骤(3)测样,得到相应结果定义为Ca;D: Take the influent and effluent water samples of the sewage treatment plant and the river water, add standard solutions of each analyte of a certain concentration to the water samples processed according to the above step (1), and after enriching and concentrating according to the above step (2), press Above-mentioned step (3) measures sample, obtains corresponding result and is defined as C a ;
E:将一定浓度的各待测物的标准溶液,不经处理,按上述步骤(3)测样得到相应结果Cb;则回收率(RE%)的计算公式为:RE%=Ca/Cb×100%E: The standard solution of each test substance of a certain concentration, without treatment, is measured according to the above step (3) to obtain the corresponding result C b ; then the calculation formula of the recovery rate (RE%) is: RE%=C a / C b × 100%
本发明考察了3个浓度的回收率,其结果如表4所示,各待测物质的回收率较高,满足分析要求。The present invention examines the recovery rates of three concentrations, and the results are shown in Table 4. The recovery rates of the substances to be tested are relatively high and meet the analysis requirements.
表4各待测物在污水处理厂进出水及河水的回收率Table 4 The recovery rate of each test object in the sewage treatment plant inflow and outflow water and river water
(五)含量分析(5) Content analysis
取污水处理厂进水和出水以及河水水样,加入一定浓度的各待测物的内标溶液按上述步骤(1)处理的水样中,按上述步骤(2)富集浓缩后,按上述步骤(3)测样,得到孕激素含量(ng/L)如表5;Take the influent and effluent water samples of the sewage treatment plant and the river water, add a certain concentration of the internal standard solution of each analyte to the water sample processed according to the above step (1), and after enrichment and concentration according to the above step (2), according to the above Step (3) measures sample, obtains progesterone content (ng/L) such as table 5;
表5污水处理厂和河水中孕激素含量(ng/L)Table 5 Progesterone content in sewage treatment plant and river water (ng/L)
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明实施例技术方案的精神和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that it can still be The technical solutions described in the foregoing embodiments are modified, or some technical features thereof are equivalently replaced; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions in the embodiments of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711083232.8A CN107884490B (en) | 2017-11-07 | 2017-11-07 | Method for simultaneously detecting multiple progestogens in environmental water body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711083232.8A CN107884490B (en) | 2017-11-07 | 2017-11-07 | Method for simultaneously detecting multiple progestogens in environmental water body |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107884490A CN107884490A (en) | 2018-04-06 |
CN107884490B true CN107884490B (en) | 2020-03-10 |
Family
ID=61778912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711083232.8A Active CN107884490B (en) | 2017-11-07 | 2017-11-07 | Method for simultaneously detecting multiple progestogens in environmental water body |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107884490B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105334282A (en) * | 2015-10-27 | 2016-02-17 | 哈尔滨工业大学 | Co-detecting method for environmental estrogens in surface water body |
CN107121518A (en) * | 2017-06-30 | 2017-09-01 | 华东理工大学 | A kind of method of phenols, estrogens and androgens incretion interferent in Sync enrichment detection drinking water |
-
2017
- 2017-11-07 CN CN201711083232.8A patent/CN107884490B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105334282A (en) * | 2015-10-27 | 2016-02-17 | 哈尔滨工业大学 | Co-detecting method for environmental estrogens in surface water body |
CN107121518A (en) * | 2017-06-30 | 2017-09-01 | 华东理工大学 | A kind of method of phenols, estrogens and androgens incretion interferent in Sync enrichment detection drinking water |
Non-Patent Citations (2)
Title |
---|
LC-MS/MS measurement of serum steroids in the clinical laboratory;Dr Emma L. Williams;《Mass spectrometry》;20170930;第20页左栏最后一段 * |
水环境中类固醇激素的污染特征及健康风险评价研究;谭丽超;《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》;20140115(第1期);第24-26页第2节 * |
Also Published As
Publication number | Publication date |
---|---|
CN107884490A (en) | 2018-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107247093B (en) | Determination method of free methoxyadrenaline substances in urine | |
Tian et al. | Rapid and sensitive determination of trace fluoroquinolone antibiotics in milk by molecularly imprinted polymer-coated stainless steel sheet electrospray ionization mass spectrometry | |
CN104483427A (en) | Method for separating, enriching and detecting 12 antibiotics in drinking water source | |
Wang et al. | Urea-formaldehyde monolithic column for hydrophilic in-tube solid-phase microextraction of aminoglycosides | |
CN113075309B (en) | Membrane-protected solid-phase microextraction device and application thereof in detection of estradiol in milk | |
Yin et al. | Determination of hyperoside and isoquercitrin in rat plasma by membrane‐protected micro‐solid‐phase extraction with high‐performance liquid chromatography | |
WO2008131648A1 (en) | Detection of blood plasma danshensu and salvianolic acid b of dissipating blood stasis botanical | |
CN102798689A (en) | Method for separation enrichment and detection of trace fluoroquinolone antibiotic in water environment | |
CN113376305A (en) | Solid-phase membrane extraction gas chromatography-mass spectrometry detection method for carbazole and polyhalogen carbazole in water body | |
CN103267820B (en) | Method for simultaneously detecting multiple estrogens in sludge | |
CN112014509A (en) | Method for synchronously determining angiotensin I and aldosterone in sample | |
CN103344732A (en) | Method for simultaneous detection of ofloxacin and sarafloxacin in water body | |
CN107884490B (en) | Method for simultaneously detecting multiple progestogens in environmental water body | |
CN104280495A (en) | Method for detecting validamycin A in water and rice plants | |
CN111337600A (en) | Method for pre-treating soil and detecting various bisphenol compounds in soil | |
CN116148401A (en) | A simultaneous and efficient method for the detection of 36 antidepressant drug residues in sludge | |
CN114354805B (en) | A method and application of MOF-based SPME-DLLME-HPLC-MS for detecting pesticides in food | |
CN111474278B (en) | Methods and kits for the detection of metabolites of macrolides | |
CN104897815B (en) | Method for analyzing active ingredients of PCPs (personal care products) in indoor dust | |
CN111665315B (en) | Detection and analysis method of anticancer drugs in natural water body | |
CN103293268A (en) | Method for detecting human urine hydrocortisone | |
Namera et al. | Monolithic spin column: a new extraction device for analysis of drugs in urine and serum by GC/MS and HPLC/MS | |
CN113030300A (en) | Method for determining antibiotics for livestock in farmland environment water | |
CN107102087A (en) | A kind of method of a variety of organic acid contents in chromatography of ions detection coptis | |
CN112198242A (en) | Method for determining aflatoxins B1, B2, G1 and G2 in angelica sinensis by ultra-high performance liquid chromatography-mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |